Trials / Completed
CompletedNCT01190865
Study of Survival Duration for Donor Skin Cells in Skin Biopsy Wounds
A Phase I Study Investigating the Survival of HP802-247 Allogeneic Cells in Excisional Acute Cutaneous Wounds
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Healthpoint · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal for this study is to examine the persistence of growth arrested,allogeneic,male-donor keratinocytes and fibroblasts when applied as product HP802-247 to the surface of acute excisional wounds in health female volunteers, as measured using Y-STR for detection of Y-chromosome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | HP802-247 | One dose of HP802-247 consisting off 260 mL containing keratinocytes and fibroblasts totaling 5.0 x 10.6 cells per mL, plus fibrin. |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-08-30
- Last updated
- 2017-07-02
- Results posted
- 2016-11-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01190865. Inclusion in this directory is not an endorsement.